MassGeneral Hospital for Children (MGHfC) is pleased to announce the launch of the Neonatal Hepatology Program, a novel multidisciplinary program that draws on the expertise of several specialties, including Neonatology, Pediatric Hepatology, Pediatric Nutrition, Pediatric Surgery, Medical Genetics and Metabolism and Pediatric Imaging. The collaboration allows for the careful evaluation and management of distinct and complex liver disease in newborns.

The goals of the program are to improve clinical care, define processes and guidelines and create an environment that fosters academic development and research for this niche. As the program develops, co-directors Uzma Shah, MBBS, and Serguei Roumiantsev, MD, PhD, hope to include other sub-specialties throughout MGHfC.

“We hope that this program stimulates creative dialogue among the various sub-specialties to tailor precise testing and management for these infants, who are usually critically ill and have a challenging road ahead,” said Shah, who is also the clinical chief of Pediatric Gastroenterology and Nutrition and the Center for Pediatric Hepatobiliary and Pancreatic Disease and the director of the Pediatric Liver Transplant Program.

The creation of the Neonatal Hepatology Program will allow providers to give better clinical care to infants with distinct and complex liver disease and formalize an already collaborative approach to patient care from various specialties and sub-specialties. “At MGHfC, we are in a unique position to have neonatal, pediatric and adult care under one roof,” said Roumiantsev, medical director of the Neonatal Intensive Care Unit (NICU) and director of NICU Transport Services. “With better clinical care, we can meet our patients’ unique needs and better support patients, families and staff.”